Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Asset Writedowns and Impairment (2016 - 2025)

Biomerica's Asset Writedowns and Impairment history spans 15 years, with the latest figure at $32000.0 for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment rose 900.0% year-over-year to $32000.0; the TTM value through Nov 2025 reached $70000.0, up 1300.0%, while the annual FY2025 figure was $8000.0, 180.0% up from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $32000.0 at Biomerica, down from $38000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $478000.0 in Q2 2023 and bottomed at -$714747.0 in Q4 2021.
  • The 5-year median for Asset Writedowns and Impairment is $6500.0 (2024), against an average of $4959.6.
  • The largest annual shift saw Asset Writedowns and Impairment soared 3398.18% in 2021 before it tumbled 6647.73% in 2023.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at -$714747.0 in 2021, then surged by 119.45% to $139000.0 in 2022, then surged by 243.88% to $478000.0 in 2023, then plummeted by 100.84% to -$4000.0 in 2024, then skyrocketed by 900.0% to $32000.0 in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Asset Writedowns and Impairment are $32000.0 (Q4 2025), $38000.0 (Q3 2025), and $1000.0 (Q2 2025).